Completed OBSERVATIONAL NCT01799408

Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis

The Effect of Intra-articular Injection of Betamethasone Acetate/Betamethasone Sodium Phosphate at the Knee Joint on the Hypothalamic-pituitary-adrenal Axis: a Case Controlled Study

Sponsor: The Nazareth Hospital, Israel

Conditions Adrenal Suppression

Updated 6 times since 2017 Last updated: Feb 23, 2013 Started: Oct 31, 2012 Primary completion: Feb 28, 2013 Completion: Feb 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01799408, this observational or N/A phase trial focuses on Adrenal Suppression and remains completed. Sponsored by The Nazareth Hospital, Israel, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Nazareth Hospital, Israel

Data source: The Nazareth Hospital, Israel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.